undefined undefined
NaN.000
NaN.00%
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 10 year...
05-18 04:00
Ascendis Pharma A/S (ASND) has released an update. Ascendis Pharma A/S, a compa...
05-17 05:27
大摩:维持Ascendis Pharma(ASND.US)评级,由持股观望调整至持股观望评级, 目标价由116.00美元调整至140.00美元。
05-17 00:06
Ascendis Pharma A/S (ASND) has released an update. Ascendis Pharma A/S has anno...
05-15 03:58
Prescription Drug User Fee Act (PDUFA) goal date extended by three months for further review of submission to August 14, 2024
05-15 02:37
Ascendis Pharma A/S (ASND) has released an update. Ascendis Pharma A/S has repo...
05-03 05:58
Ascendis Pharma A/S (ASND) has released an update. Ascendis Pharma A/S, a bioph...
05-03 05:57
Ascendis Pharma A/S (ASND) has released an update. Ascendis Pharma A/S has anno...
05-03 04:58
Ascendis Pharma Q1 Sales €95.894M Beat €79.492M Estimate
05-03 04:46
Ascendis Pharma's (NYSE:ASND) short percent of float has risen 13.75% since its...
04-26 23:30